PRKG1 and cardiac hypertrophy: Notably, the cGMP-PKG signaling pathway, which mediates interactions between cyclic guanosine monophosphate (cGMP) and protein kinase G (PKG), plays a crucial role in cardiac hypertrophy and heart failure management (15, 16).